Results
1 -
7 of
7
(Click
here to explore results)
- Synthesis of 1,4-triazole linked zanamivir dimers as highly potent inhibitors of influenza A and B. Benjamin H. Fraser, Stephanie Hamilton, Anwen M. Krause-Heuer, Philip J. Wright, Ivan Greguric, Simon P. Tucker, Alistair G. Draffan, Valery V. Fokin, K. Barry Sharpless
, Med. Chem. Commun.
, 2013
, 4
, 383
- Biocatalytic routes to anti-viral agents and their synthetic intermediates. Sjoerd Slagman, Wolf-Dieter Fessner
, Chem. Soc. Rev.
, 2021
, 50
, 1968
- The value of pyrans as anticancer scaffolds in medicinal chemistry. Dinesh Kumar, Pooja Sharma, Harmanpreet Singh, Kunal Nepali, Girish Kumar Gupta, Subheet Kumar Jain, Fidele Ntie-Kang
, RSC Adv.
, 2017
, 7
, 36977
- Structure-based design of 5′-substituted 1,2,3-triazolylated oseltamivir derivatives as potent influenza neuraminidase inhibitors. Pengfei Wang, Babayemi O. Oladejo, Chenning Li, Lifeng Fu, Shanshan Zhang, Jianxun Qi, Xun Lv, Xuebing Li
, RSC Adv.
, 2021
, 11
, 9528
- Anti-influenza agents from Traditional Chinese Medicine. Hu Ge, Yi-Fei Wang, Jun Xu, Qiong Gu, Hai-Bo Liu, Pei-Gen Xiao, Jiaju Zhou, Yanhuai Liu, Zirong Yang, Hua Su
, Nat. Prod. Rep.
, 2010
, 27
, 1758
- Recent advances of phenotypic screening strategies in the application of anti-influenza virus drug discovery. Huinan Jia, Lide Hu, Jiwei Zhang, Xing Huang, Yuanmin Jiang, Guanyu Dong, Chuanfeng Liu, Xinyong Liu, Meehyein Kim, Peng Zhan
, RSC Med. Chem.
, 2024
, 15
, 70
- Natural product and natural product derived drugs in clinical trials. Mark S. Butler, Avril A. B. Robertson, Matthew A. Cooper
, Nat. Prod. Rep.
, 2014
, 31
, 1612